Differential analysis of chromatin accessibility and histone modifications for predicting mouse developmental enhancers by Fu, Shaliu et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Program in Bioinformatics and Integrative 
Biology Publications and Presentations 
Program in Bioinformatics and Integrative 
Biology 
2018-08-22 
Differential analysis of chromatin accessibility and histone 
modifications for predicting mouse developmental enhancers 
Shaliu Fu 
Tongji University,China 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/bioinformatics_pubs 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons, Bioinformatics Commons, Cell 
and Developmental Biology Commons, Computational Biology Commons, Genomics Commons, and the 
Integrative Biology Commons 
Repository Citation 
Fu S, Wang Q, Moore JE, Purcaro MJ, Pratt HE, Fan K, Gu C, Jiang C, Zhu R, Kundaje A, Lu A, Weng Z. 
(2018). Differential analysis of chromatin accessibility and histone modifications for predicting mouse 
developmental enhancers. Program in Bioinformatics and Integrative Biology Publications and 
Presentations. https://doi.org/10.1093/nar/gky753. Retrieved from https://escholarship.umassmed.edu/
bioinformatics_pubs/133 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Program in 
Bioinformatics and Integrative Biology Publications and Presentations by an authorized administrator of 
eScholarship@UMMS. For more information, please contact Lisa.Palmer@umassmed.edu. 
Nucleic Acids Research, 2018 1
doi: 10.1093/nar/gky753
Differential analysis of chromatin accessibility and
histone modifications for predicting mouse
developmental enhancers
Shaliu Fu1,†, Qin Wang1,†, Jill E. Moore2, Michael J. Purcaro2, Henry E. Pratt2, Kaili Fan1,
Cuihua Gu1, Cizhong Jiang1, Ruixin Zhu1, Anshul Kundaje3, Aiping Lu1 and
Zhiping Weng1,2,*
1Clinical Translational Research Center, Shanghai Pulmonary Hospital, School of Life Sciences and Technology,
Tongji University, Shanghai 200092, China, 2Program in Bioinformatics and Integrative Biology, University of
Massachusetts Medical School, Worcester, MA 01605, USA and 3Department of Genetics, School of Medicine,
Department of Computer Science, Stanford University, Stanford, CA 94305, USA
Received February 02, 2018; Revised July 15, 2018; Editorial Decision August 06, 2018; Accepted August 08, 2018
ABSTRACT
Enhancers are distal cis-regulatory elements that
modulate gene expression. They are depleted of nu-
cleosomes and enriched in specific histone modifi-
cations; thus, calling DNase-seq and histone mark
ChIP-seq peaks can predict enhancers. We eval-
uated nine peak-calling algorithms for predicting
enhancers validated by transgenic mouse assays.
DNase and H3K27ac peaks were consistently more
predictive than H3K4me1/2/3 and H3K9ac peaks.
DFilter and Hotspot2 were the best DNase peak
callers, while HOMER, MUSIC, MACS2, DFilter and
F-seq were the best H3K27ac peak callers. We ob-
served that the differential DNase or H3K27ac sig-
nals between two distant tissues increased the area
under the precision-recall curve (PR-AUC) of DNase
peaks by 17.5–166.7% and that of H3K27ac peaks
by 7.1–22.2%. We further improved this differential
signal method using multiple contrast tissues. Eval-
uated using a blind test, the differential H3K27ac sig-
nal method substantially improved PR-AUC from 0.48
to 0.75 for predicting heart enhancers. We further val-
idated our approach using postnatal retina and cere-
bral cortex enhancers identified by massively paral-
lel reporter assays, and observed improvements for
both tissues. In summary, we compared nine peak
callers and devised a superior method for predicting
tissue-specific mouse developmental enhancers by
reranking the called peaks.
INTRODUCTION
In metazoans, enhancers are a major class of regulatory
elements that drive cell-type-specific and time-restricted
patterns of gene expression (1,2). Population-scale ge-
netic studies indicate that many sequence variants associ-
ated with human diseases reside in enhancers (3,4). Thus,
genome-wide maps of enhancers and their activity patterns
across cell and tissue types can provide tremendous insights
into mechanisms of gene regulation and disease etiology.
In recent years, epigenetic approaches have greatly ad-
vanced genome-wide identification of enhancers (5). En-
hancers are enriched in several histone modifications, in-
cluding monomethylation of histone H3 at lysine residue 4
(H3K4me1) and acetylation of H3 at lysine 27 (H3K27ac)
(6,7). Chromatin immunoprecipitation of histone modifica-
tions followed by sequencing (ChIP-seq) is a powerful tech-
nique for mapping histone marks genome-wide. A related
approach is to performChIP-seq on the histone acetyltrans-
ferases P300 or CBP (8). Because most enhancers are in
open chromatin regions, another approach is to treat chro-
matin with Deoxyribonuclease I (DNase I) and sequence
the liberated DNA (DNase-seq) (2,9). ATAC-seq is another
technique for detecting open chromatin regions that of-
fers some practical advantages over DNase-seq (10). The
CpG dinucleotides in enhancers remain unmethylated so
whole-genome bisulfite sequencing is another type of high-
throughput data that can be used for identifying enhancers
(11).
A number of supervised machine-learning algorithms
have been developed to integrate ChIP-seq, DNase-seq,
ATAC-seq and DNA methylation data along with annota-
tions such as evolutionary conservation and sequence mo-
tifs to predict enhancers (12–17). Some of these methods,
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e.g. REPTILE (12), RFECS (16) and LEG (18), combine
multiple types of epigenetic signals in a particular cell or
tissue type to predict enhancers in the same cell or tis-
sue type, while other algorithms, e.g. PEDLA (13) and En-
hancerFinder (14), use thousands of features, including fea-
tures from distant cell types. Being supervised, these algo-
rithms are trained using known enhancers. There are also
unsupervised algorithms that integrate multiple types of
epigenetic signals in a cell type to define a set of chromatin
states, including enhancers (19–21).
Despite the success of these algorithms, many studies
continue to use just one or two types of epigenetic signal
to define enhancers in the specified cell type. This is be-
cause it is costly to performmultiple assays, especially when
many samples are studied. For example, Pennacchio and
colleagues used ChIP-seq datasets of H3K27ac and P300
in human and mouse heart tissues to build a compendium
of heart enhancers (22). Sun et al. used H3K27ac ChIP-seq
to define enhancers in the brain tissues of a large cohort
of autism spectrum disorder patients and controls (23). To
call enhancers based on DNase-seq, ATAC-seq, or ChIP-
seq data, one first identifies the genomic regions with sig-
nificantly high signal, called peaks. (DNase peaks are com-
monly known as DNase hypersensitive sites or DHSs. Here,
we also call themDNase peaks for convenience.) Computa-
tional algorithms devised for this purpose are peak-calling
algorithms or peak callers.
More than thirty peak callers have been developed for
ChIP-seq data over the past decade (see review (24)). Some
of these algorithms are designed for finding punctate peaks
such as those of transcription factors (25), while others
identify broad domains of histone marks such as H3K9me3
(26,27). The widths of DNase-seq and ATAC-seq peaks lie
midway between punctate and broad, and these peaks have
characteristic shapes that differ from TF and histone mark
ChIP-seq peaks. Thus, a subset of algorithms designed for
both punctate and broad ChIP-seq signals can also be con-
figured to work for DNase-seq and ATAC-seq data.
Several benchmarking studies have compared algorithms
for their consistency in finding histone mark peaks (28–31)
and DNase peaks (32), with several studies also evaluating
these peaks’ efficacy for identifying promoters. However, to
the best of our knowledge, there is not yet a study to com-
pare the performance of peak callers for finding enhancers.
As described above, the utility of enhancer-focused peak
calling is apparent: these peaks can guide the identification
of enhancers in a cell or tissue type at a developmental stage,
and the predicted enhancers can be experimentally tested
(22) and can be used for studying the genetic basis of gene
regulation in diseases (23,33).
Pennacchio and colleagues have established transgenic
assays to test enhancer function in embryonic day 11.5
(e11.5) mice (34); their results for over 2500 genomic re-
gions are provided in the VISTA Enhancer Database (35).
Using these VISTA regions as the gold standard, we eval-
uated the peaks called by nine algorithms for the DNase-
seq and histone mark ChIP-seq data of e11.5 mouse tissues:
MACS2 (36), F-seq (37), HOMER (38), Hotspot (39) and
its newer version Hotspot2, MOSAiCS (40), RSEG (26),
BCP (41), DFilter (42) and MUSIC (43). Among these al-
gorithms, Hotspot was designed for DNase-seq data (39),
DFilter, HOMER, MACS2 and F-seq were designed for
both DNase-seq and ChIP-seq data, and the remaining al-
gorithms were designed only for ChIP-seq data. We sam-
pled these methods as they were representative of the vari-
ous known methodological and statistical approaches and
could potentially work well on DNase-seq data and ChIP-
seq data for the five histone marks that have been shown
to be predictive of enhancers. Besides the aforementioned
H3K4me1 and H3K27ac, three additional histone marks
were analyzed: H3K4me2, enriched in promoters and some
enhancers (1,44); H3K4me3, enriched in promoters and
present at enhancers (6,45,46) and H3K9ac, enriched in ac-
tively transcribed promoters and active enhancers (47,48).
Using tissue-specific VISTA enhancers as the gold stan-
dard, we found DHSs and H3K27ac peaks to be more pre-
dictive of enhancers than the peaks of the other histone
marks (H3K4me1, H3K4me2, H3K4me3 and H3K9ac).
We found thatDNase peaks called byDFilter andHotspot2
outperformed those called by MACS2 and HOMER, and
H3K27ac ChIP-seq peaks called by HOMER, MUSIC
punctate, MACS2, F-seq and Dfilter outperformed the
peaks by the other algorithms we tested. Furthermore,
the DHSs and H3K27ac peaks called by these algorithms
showed a high concordance between biological replicates
and were most stable upon downsampling of reads to sim-
ulate a lower sequencing depth.
Motivated by the knowledge that enhancers are highly
tissue-specific, we asked whether contrasting the DNase
and H3K27ac signals between different tissues would lead
to improved prediction performance. Indeed, we found
that contrasting DNase and H3K27ac signals in one tissue
against another tissue with a substantially different regula-
tory landscape (e.g. midbrain versus limb) led to a drastic
improvement in predicting VISTA enhancers, especially for
DNase peaks. For DFilter-called DNase peaks, the areas
under the precision-recall curves (PR-AUC) were improved
by 17.5–33.3% in four tissues and 166.7% in craniofacial
prominence (abbreviated as face). The same approach also
improved the performance of H3K27ac peaks, albeit to a
lesser extent (7.1–22.2% improvement).We further explored
using combinations of tissues as the background, and found
that a panel of tissues, weighted by the distances between
their regulatory landscapes and that of the tissue under in-
vestigation, led to the best performance.
We validated our differential-signal approach in two
ways. First, we conducted a blind test of the prediction
of mouse e12.5 enhancers from the VISTA database, find-
ing that differential H3K27ac signal improved the PR-AUC
from 0.48 to 0.75 for heart enhancers. Second, we evalu-
ated our approach on a different benchmark, roughly 3,500
DNase hypersensitive sites tested using massively parallel
reporter assays (MPRA) by ex vivo plasmid electroporation
into the mouse retina and in vivo adeno-associated virus
(AAV) injection into the mouse cerebral cortex (49). Dif-
ferential DNase signal improved the PR-AUC of predict-
ing retinal enhancers from 0.28 to 0.42, and a modest im-
provement was also observed for predicting cerebral cortex
enhancers.
In summary, we have evaluated and enhanced the general
approach of using DNase-seq or histone mark ChIP-seq
data for identifying tissue-specific enhancers. We found that
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computing the differential signal in a given tissue against a
panel of background tissues led to the best performance.
Furthermore, because our refined approach is general, it
can be applied to the tens of thousands of publicly-available
DNase-seq and H3K27ac ChIP-seq datasets (49).
MATERIALS AND METHODS
Datasets
We used all histone mark ChIP-seq, DNase-seq and RNA-
seq datasets generated by the ENCODE Consortium for
e11.5 mouse tissues. We downloaded the alignment files
(in BAM format) and gene expression tables of these
datasets from the ENCODE Portal (http://encodeproject.
org). The H3K4me1, H3K4me2, H3K4me3, H3K9ac,
H3K27ac ChIP-seq data were produced by the Ren lab
for eight e11.5 mouse tissues (forebrain, midbrain, hind-
brain, neural tube, craniofacial prominence, liver, limb,
heart) and the DNase-seq data were produced by the Stam-
atoyannopoulos lab for five e11.5 mouse tissues (midbrain,
hindbrain, neural tube, craniofacial prominence, and limb).
We also downloaded the e12.5 H3K27ac ChIP-seq data in
forebrain, heart and limb from the ENCODE portal to per-
form a blind test of our differential signal method (see the
penultimate section of Methods). These data were also gen-
erated by the Ren lab. The ENCODE accession numbers for
all above datasets are listed in Supplementary Table S1A.
The craniofacial prominence tissue is abbreviated as face
throughout this work.We used themouse genome assembly
mm10 for all analyses.
Genomic regions tested by transgenic mouse assays us-
ing e11.5 tissues were downloaded from the VISTA en-
hancer browser (35) on 6 November 2016 (https://enhancer.
lbl.gov/). The database contained 2581 regions with coordi-
nates in mouse genome assembly mm9 or human genome
assembly hg19, among which 2556 regions could be lifted
over to the mouse assembly mm10. These VISTA regions
are listed in Supplementary Table S2. On 6November 2016,
there were no e12.5 enhancers at the VISTA browser. Sub-
sequently, 150 regions were tested for their activities in e12.5
tissues (see the penultimate section of Methods) and we
used these regions for a blind test of our methods.
Peak-calling algorithms
Among the large number of available peak callers, we sam-
pled nine algorithms that are easy to use and are rep-
resentative of the key methodological and statistical ap-
proaches (Supplementary Methods): MACS v2.1.0 (36)
(called MACS2), F-Seq v1.8.5 (37), HOMER v4.7.2 (38),
RSEG v0.4.9 (26), MOSAiCS v2.4.0 (40), BCP v1.1 (41),
DFilter v1.5 (42), MUSIC (43) and Hotspot v5 (39). We
applied the first eight algorithms for histone ChIP-seq data.
Four of these algorithms can also be applied to DNase-seq
data: DFilter, MACS2, HOMER and F-seq. However, F-
Seq failed to run on several DNase-seq datasets, so we only
evaluated the other three algorithms for DNase-seq data.
In addition, we tested Hotspot v5 (39) and Hotspot2 for
DNase-seq data. As recommended by the Hotspot devel-
opers, we evaluated the peaks called by Hotspot, which are
all 151 bp long, and the DHSs called by Hotspot2 (these
DHSs are also named hotspots in the program’s outputs),
which are∼300 bp long. For simplicity, we refer to Hotspot
peaks and Hotspot2 DHSs as DNase peaks henceforth.
We ran these algorithms using their recommended pa-
rameters for DNase-seq and histone mark ChIP-seq data
respectively, and for specific histone marks if provided. The
programs and their parameter settings are listed in Supple-
mentary Tables S3. We did not tune the parameters, be-
cause Micsinai et al. performed extensive parameter tun-
ing for a number of algorithms and concluded that the rec-
ommended parameters worked well for most of these algo-
rithms (31). For MUSIC, we called ‘punctate peaks’ and
‘broad peaks’ and evaluated these two sets of peaks sepa-
rately. For MACS2, we only evaluated narrow peaks as the
P-values of its broad peaks and gapped peaks yielded poor
performance. The peak lists were ranked as recommended
by each algorithm: MACS2, Hotspot, and Hotspot2 peaks
were ranked byP-value then signal, DFilter byP-value then
max score, F-Seq by signal, MUSIC by P-value, HOMER
by normalized tag count,MOSAiCS by average logP-value,
BCP by posterior mean and RSEG by domain score.
Six of the algorithms (MACS2, BCP, F-Seq, HOMER,
MUSIC and RSEG) required the average length of the se-
quencedDNA fragments as a parameter. All reads from the
datasets were single-ended; we used the SPP algorithm (50)
to estimate the average fragment length for each dataset us-
ing 5 million randomly-sampled reads.
Resizing peaks and excluding TSS-proximal peaks
The peaks called by different algorithms had different
widths. To achieve a fair comparison of performance for
predicting VISTA enhancers, motif enrichment analysis,
and gene expression analysis (see below), we resized each
peak in the final peak list produced by the uniform process-
ing pipeline to a fixed length (2 kb for histone mark peaks
and 300 bp for DHSs) centered on its summit. The summit
of a peak is defined as the position in the original peak with
the highest H3K27ac ChIP-seq or DNase-seq signal. Some
of the originally called H3K27ac peaks or DNase might be
shorter than 2 kb or 300 bp; thus, after resizing, they might
overlap each other. We merged the overlapping peaks, av-
eraged the coordinates of their summits, and resized again
to 2k or 300 bp centered on the new summit. The merged
and twice-resized peakwas assigned the best rank of its con-
stituent original peaks.
Because the VISTA enhancer team has intentionally
avoided testing regions that are near annotated transcrip-
tion start sites (TSSs), we excluded all H3K27ac andDNase
peaks that were within 2 kb of a GENCODE-annotated
TSS (Version M8) from our analysis henceforth, namely
VISTA enhancer prediction, distance to the expressed genes
and motif enrichment, as described in the remaining sec-
tions of Materials and Methods.
Metric for evaluating enhancer predictions
We evaluated how accurately a final, resized, and TSS-
distal peak list called using a histone mark ChIP-seq or
a DNase-seq dataset could predict enhancers, using the
genomic regions downloaded from the VISTA database
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(34,51) as of Nov, 2016 as the gold standard. These VISTA
regions had been experimentally tested for enhancer ac-
tivity in e11.5 transgenic mouse assays; a VISTA region
is deemed a VISTA enhancer for a particular tissue if the
transgenic mice show reproducible reporter activity for this
tissue in multiple mouse embryos, regardless of the results
for the other tissues. For example, a VISTA enhancer that
has reporter activity for both limb and heart is considered
a positive enhancer for limb and heart but negative for all
other tissues. Supplementary Table S2 shows the VISTA en-
hancers used in our study and the number of positives and
negatives in each tissue.
We computed the area under Precision-Recall curve (PR-
AUC) to evaluate how well the ranked lists of the final, re-
sized, TSS-distal DNase or histone-mark peaks could pre-
dict VISTA enhancers. If a DNase or histone mark peak
overlapped a VISTA positive (or negative) region by at least
1 bp, it was considered a true positive (or false positive) pre-
diction. Precision is the fraction of true positives (i.e. DNase
or histone mark peaks that were ranked above a certain
threshold and overlapped a VISTA enhancer in a particu-
lar tissue) among a set of predicted regions (i.e. DNase or
histone mark peaks that were ranked above the threshold
and overlapped a VISTA region). Recall (equivalent to sen-
sitivity) is the fraction of true positives out of all positives
(all VISTA enhancers in a particular tissue). We calculated
the PR-AUC using the auc function in the flux package in
R. If a peak list overlaps all positive VISTA enhancers, its
PR curve would extend all the way to the 100% recall. Note
that for any PR curve, the precision at the 100% recall is sim-
ply the percentage of positives in the test set, independent of
the performance of the predictions. Because different peak
lists may overlap different numbers of positive VISTA en-
hancers in a given tissue, the PR curves of these peak lists
may end at various locations before the 100% recall. For
their PR-AUCs to be comparable, we include the last point
(percentage of positives at 100% recall), which is common
to all peak lists, in the PR-AUC calculation.
Enrichment of transcription factor binding
As shown in Results, the top 2000 DNase peaks called
by DFilter did not overlap many of the top 2000 peaks
of Hotspot2, MACS2 or HOMER, while the top peaks
of the latter three algorithms overlapped substantially. We
assessed whether these peaks were enriched in known se-
quence motifs of transcriptional factors. We first con-
structed two sets of peakswith equal numbers, one set called
by DFilter only, and the other set by two or all three of
the other algorithms but not by DFilter. We then searched
for enriched motifs in these two sets of peaks using the
findMotifsGenome.pl script in the HOMER suite of
tools (38), which is independent of HOMER’s peak caller
being evaluated in this study. We used the script to com-
pute a P-value for each motif from a motif library pro-
vided by HOMER. We identified the motifs with a P-value
lower than 0.01 in at least one peak set and then used a
paired Wilcoxon signed-rank test to compare the -log10 P-
values of all such motifs between the two peak sets. Re-
ciprocally, we performed de novo motif finding on the top
2000 DNase peaks shared by the Hotspot2, MACS2 and
HOMER peak callers. To investigate how many of the top
2000 DNase peaks were bound by CTCF, we overlapped
these peaks in e11.5 hindbrain and midbrain with postna-
tal 0 day CTCF peaks in hindbrain (ENCSR150RGT) and
midbrain (ENCSR985ZTV) using the intersect function in
BEDTools (52).
Using differential signal levels of DHSs and H3K27ac peaks
between two tissue types to predict enhancers
We reranked the DNase peaks called by DFilter or
Hotspot2 and the H3K27ac peaks called by HOMER by
the differential signal in the tissue of interest (X) against an-
other tissue (called the contrast tissue, C). We tested three
metrics for evaluating the difference in signals: (i) signal
(S) defined as control-normalized read counts computed by
MACS2 (called ‘fold change over control’), averaged over
all positions in a peak: S(X) – S(C); (ii) the signal defined as
per (i) and further log transformed;: log(S(X)) – log (S(C))
and (iii) the signal defined as per (ii) and then transformed
into a Z-score: Z(log(S(X))) – Z(log(S(C))). Note that the
distribution of log-signal at peaks is approximately Gaus-
sian, hence justifying the Z-score computation.
We also evaluated which contrast tissue could lead to the
best enhancer prediction performance. First, for each set of
peaks called in a tissue under investigation, we calculated
the log of the read counts falling within the peaks for each
contrast tissue. Then, to estimate the relative distance be-
tween each contrast tissue and the tissue under investiga-
tion, we applied principal component analysis (PCA) on all
tissues based on the 500 peaks with the highest variances
across tissues, using the ‘plotPCA’ function in Bioconduc-
tor package DESeq2 (53). The distance between two tissues
is defined as the Euclidean distance between first two prin-
cipal components (PCs). We used the top two PCs for most
calculations, except for DNase data from 24 tissues where
the top two PCs did not capture sufficient variation in the
data; for these tissues, we used the top six PCs. The tissues
were weighted proportionally to their Euclidean distances
to the tissue under investigation, with the weights scaled to
sum to 1. The datasets for all contrast tissues are listed in
Supplementary Table S1B and C.
We performed the same motif enrichment analysis de-
scribed in the previous section on the top 2000 final, resized,
TSS-distal peaks (DFilter or Hotspot2 peaks for DNase
and HOMER peaks for H3K27ac) and the top 2000 peaks
ranked by differential signals, and tested whether these two
sets of peaks differed in motif enrichment.
Differential expression analysis of the neighboring genes
To estimate the gene activation potential of DNase and
H3K27ac peaks, we investigated the tissue specificity of
neighboring genes among eight e11.5 tissues. First, we iden-
tified differentially expressed genes in each tissue compared
with tissues of different origins. The eight e11.5 tissues
fell into two groups––brain-related tissues (forebrain, mid-
brain, hindbrain and neural tubes) and non-brain-related
tissues (face, limb, heart, and liver). We used DESeq2 (53)
to perform differential expression analysis between each tis-
sue and the four tissues in the other group. We then iden-
tified genes that were expressed at ≥1 FPKM in at least
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one of the eight e11.5 tissues and showed significant up-
regulation (adjusted P-value ≤ 0.05) in each tissue vs. the
tissues in the other group. Finally, we selected the top 2000
promoter-distal peaks in each peak list and summarized the
log2 fold change values of their upregulated neighboring
genes. The neighboring genes of a DNase or an H3K27ac
peak are defined as the genes with aGENCODE-annotated
TSS that is located within 50 kb of the peak, identified using
the window function in BEDTools (52). A Wilcoxon rank
sum test was used to compare the upregulated neighboring
genes’ log2 fold change levels between the top 2000 DFilter,
Hotspot2 or HOMER peaks ranked by differential signals
and the top 2000 peaks originally ranked by the correspond-
ing algorithms.
Ablind test of the differentialH3K27acmethod for predicting
e12.5 enhancers
We tested the performance of our differential signal method
formulated using e11.5 VISTA enhancers for predicting
VISTA enhancers in the e12.5 forebrain, heart and limb.
Note that when we downloaded the VISTA enhancers in
November 2016, all of them were for e11.5, and e12.5
VISTA enhancers became available only later. First, EN-
CODE H3K27ac peaks were downloaded from the EN-
CODE Portal. The peaks were processed with the EN-
CODE uniform processing pipeline, which uses MACS2 as
a peak caller and ranks peaks by P-value (signal is used
to break ties). Second, we called peaks with the HOMER
algorithm, using the same parameters as used for pre-
dicting e11.5 enhancers. Third, we ranked the HOMER
peaks by contrasting H3K27ac signals in the e12.5 fore-
brain, heart or limb against the other 16 tissues (eight
e11.5 tissues, the other seven e12.5 tissues, and postna-
tal day 0 or P0 intestine). We submitted predictions from
our differential signal method to the ENCODE Portal
on 21 March 2017 (accession numbers: ENCFF091DKM,
ENCFF635WWK and ENCFF760OKN), before the Pen-
nacchio lab released the experimental results at the VISTA
database on 2 May 2017. The experimental method of
transgenic mouse assays and results for these regions are
described in a preprint (BioRxiv: https://doi.org/10.1101/
166652). These e12.5 VISTA regions are provided in Sup-
plementary Table S4.
Prediction of MPRA CRE-seq enhancers in retina and cere-
bral cortex
We further tested the performance of our differential sig-
nal method for predicting enhancers identified by mas-
sively parallel reporter assays (MPRA) in postnatal day 0
retina and adult cerebral cortex (54). We selected ‘high ex-
pression’ constructs as positive enhancer regions and ‘not
high expression’ constructs as negative regions, as defined
by (54). Overlapping constructs were merged to form a
contiguous region, yielding 320 positive and 3019 nega-
tive regions in the retina, and 110 positive and 3272 neg-
ative regions in the cerebral cortex (Supplementary Table
S5). We then downloaded DNase-seq datasets in retina
postnatal day 7 and forebrain postnatal day 0 (ENCODE
accessions: ENCSR000CNU and ENCSR791AJY), and
H3K27ac ChIP-seq datasets in forebrain postnatal day
0 (ENCODE accession: ENCSR094TTT) from the EN-
CODE portal. We re-ranked DNase peaks by contrasting
the retina or forebrain DNase signals against 23 others
tissues (Supplementary Table S1B), and we re-ranked the
H3K27ac peaks by contrasting theH3K27ac signals in fore-
brain against 17 other tissues (Supplementary Table S1C)
prior to prediction.
RESULTS
Comparison of peak callers
We compared nine peak callers: DFilter, HOMER,
Hotspot/Hotspot2 and MACS2 for DNase-seq data;
and BCP, DFilter, F-seq, HOMER, MACS2, MOSAiCS,
MUSIC and RSEG for histone mark ChIP-seq data (see
Supplementary Methods for a brief description of the key
features of these algorithms and our rationale of choosing
them). We first compared the numbers and lengths of the
peaks called by these algorithms on the same DNase-seq
or histone-mark ChIP-seq data (Supplementary Results;
Supplementary Figure S1A and B; Supplementary Table
S6). We further assessed the consistency of the peaks after
halving or quartering sequencing depth (Supplementary
Results; Supplementary Figures S1C, D, S2 and S3). We
found the DNase-seq algorithms to differ in the peaks
they call, consistency between biological replicates, and
robustness against downsampling, and several H3K27ac
algorithms achieved high consistency and robustness. We
implemented the ENCODE uniform processing pipeline
(Supplementary Figure S4) to filter out peaks that were
not consistently called between biological replicates
(Supplementary Results; Supplementary Figure S5–S10;
Supplementary Table S7). After comprehensive compari-
son of the peak callers, we decided to perform subsequent
analyses using the final, resized DNase and histone-mark
peaks produced by the uniform processing pipeline with
each peak caller.
The performance of DNase and histone mark peaks for pre-
dicting VISTA enhancers
We compared the performance of the final, resized, TSS-
distal peaks of DNase and histone marks for predicting
VISTA enhancers (Methods). We used five tissues for test-
ing both DNase and histone mark data and two additional
tissues for testing histone mark data alone––there were no
DNase-seq data for the e11.5 forebrain or heart. Despite
having histonemarkChIP-seq data, liver has only eight pos-
itive VISTA enhancers, so we left it out of the PR-AUC
evaluation. Figure 1A shows that H3K27ac and DNase
achieved substantially higher PR-AUCs than the other four
histone marks: the median PR-AUCs across five tissues
were 0.35, 0.33, 0.25, 0.20, 0.19, 0.17 for H3K27ac, DNase,
H3K4me1, H3K4me2, H3K9ac andH3K4me3 respectively
when the best algorithm for each tissue was used. H3K27ac
also outperformed the other four histone marks by simi-
lar margins in forebrain and heart (Supplementary Figures
S11). Because our goal was to search for the best method for
predicting enhancers, we focused on DNase and H3K27ac
for the rest of this study. For completeness, the PR-AUCs
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Figure 1. The performance of H3K27ac and DNase-seq peaks for predicting VISTA enhancers in the corresponding tissue, assessed by PR-AUC values.
Final, resized, TSS-distal peaks were used for comparing the peak calling algorithms. (A) Boxplots of the comparison of DNase peaks (four algorithms in
five tissues) with the peaks of five histone marks (eight algorithms in the same five tissues). (B–F) Barplots of the top six methods for DNase peaks (blue)
and H3K27ac peaks (red) in (B) face, (C) hindbrain, (D) limb, (E) midbrain and (F) neural tube.
for individual algorithms on DNase and all five histone
marks are provided in Supplementary Tables S8).
Among the five tissues with both DNase and H3K27ac
data, DNase performed better for limb and neural tube,
while H3K27ac performed better for face, hindbrain, and
midbrain (Figure 1B–F for the top six algorithms and Sup-
plementary Tables S8A-B for all algorithms). Note that the
performance of the top algorithms differed among the tis-
sues because of varying numbers of VISTA enhancers in
these tissues: 3.5%VISTA regions were active in face, 13.5%
in hindbrain, 11.0% in limb, 15.0% in midbrain and 9.7% in
neural tube, and these fractions are highly correlated with
the average PR-AUC of the top six methods in each tissue
(correlation coefficientR2 = 0.92). Nevertheless, the perfor-
mance of different algorithms in the same tissue can be di-
rectly compared. For DNase, DFilter was the most predic-
tive, with Hotspot2 being a close second (mean PR-AUCs
across five tissues = 0.31 and 0.29 respectively). Hotspot2
outperformed Hotspot for all five tissues. Among the his-
tone mark peak callers, HOMER achieved the highest PR-
AUC, followed by MUSIC-punctate, MACS2, F-seq and
DFilter (mean PR-AUCs across seven tissues = 0.34, 0.33,
0.31, 0.31 and 0.31 respectively). For MUSIC, the punc-
tate mode outperformed the broad mode for all seven tis-
sues. Although the absolute differences of PR-AUC among
the algorithms were small, the relative rankings of the algo-
rithms were consistent across the tissues.
The top DNase peaks called by DFilter were mostly dis-
tinct from the DNase peaks called by Hotspot2, MACS2 and
HOMER
For limb DNase-seq data, DFilter peaks achieved a higher
PR-AUC (0.40) than the other peak callers. The top DFil-
ter peaks had a much higher precision (65% for the top 200
peaks) than the top peaks of the other algorithms (39% for
Hotspot2, the next best algorithm; Figure 2A). We omit
Hotspot henceforth because Hotspot2 was nearly always
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Figure 2. Identifying VISTA enhancers in limb using DNase-seq and H3K27ac peaks. Final, resized, TSS-distal peaks were used for comparison. The
circle in each PR curve indicates the 200th prediction. (A) PR curves for DNase peak callers. PR-AUC values are indicated in the legend. (B) Venn diagram
of the top 200 peaks by each DNase peak callers. Among the top 200 peaks called by DFilter, 129 were not called by the other three algorithms. (C) PR
curves for four H3K27ac peak callers. PR-AUC values are indicated in the legend. (D) Venn diagram of the top 200 peaks by each of the four H3K27ac
peak callers.
superior. The PR curve for DFilter lay above the curves
of the other algorithms throughout the entire range of re-
call even though the differences became smaller when more
predictions were included. The top-ranked DNase peaks
by DFilter also achieved a higher precision than the top-
rankingH3K27ac peaks called byHOMER (Figure 2A ver-
sus C).
We asked how much the top predictions of the four al-
gorithms differed. Figure 2B shows the overlap among the
top 200 peaks of the four algorithms in limb––only 11 peaks
were ranked in the top 200 by all four algorithms; of these,
four overlapped with VISTA regions but none of the four
were active in limb. Among DFilter’s top 200 peaks, 129
were unique to DFilter; among these, 37 overlapped VISTA
regions and 28 were positive in limb (75.7% precision). The
other three algorithms called fewer unique peaks (44, 40,
and 66 for Hotspot2, MACS2, and HOMER), and few of
their unique peaks overlappedwith VISTA regions (7, 2 and
2). Those that did overlap achieved lower precisions than
DFilter-only peaks (57%, 0% and 0%).
Wemanually inspected the top 20 peaks called by each al-
gorithm in limb with the UCSC genome browser (Supple-
mentary Figures S12–S15) to identify features that might
differentiate the algorithms. Of the top 20 DFilter peaks,
nine (DFilter ranks 7–12, 16 and 18–19) were not ranked
in the top 200 by any of the other algorithms. Among
these, four peaks (7th, 9th, 10th and 12th) overlapped pos-
itive VISTA enhancers and only one peak (18th) over-
lapped negative VISTA regions in limb. One common fea-
ture shared among the top-ranked DFilter peaks was their
broad and multimodal signals, suggesting the presence of
multiple evicted nucleosomes at these open chromatin re-
gions. The DNase signal climaxes at the trough of the sur-
rounding H3K27ac signal, which indicate the positions of
the remaining nucleosomes (Supplementary Figure S12).
In contrast, most of the top 20 peaks called by the other
three algorithms showed sharp and unimodal signals, sug-
gesting a single evicted nucleosome (SupplementaryFigures
S13–S15). Most of these unimodal, high-signal peaks were
ranked poorly by DFilter.
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Formidbrain, the H3K27ac peaks outperformed the best
set of DNase peaks (Figure 1D); nevertheless, DFilter re-
mained the best DNase peak caller (Supplementary Figure
S16A). Among the top 200 peaks called by DFilter in mid-
brain, 120 were not shared by the other algorithms; 23 of
these peaks overlapped VISTA regions and 16 were tested
positive (precision = 69.6%; Supplementary Figure S16B).
The PR curves and the four-way Venn diagrams for the
other three tissues are shown in Supplementary Figures S17
and S18.
We also compared the top 2000 DNase peaks called by
the four algorithms in each tissue and observed similar re-
sults as described above: DFilter peaks were unique (Sup-
plementary Figure S19) and tended to be broad and multi-
modal (UCSC genome browser shots not shown).
DFilter-only and shared DNase peaks differ in TF motifs and
TF binding
To provide more quantitative comparison between the
DFilter-only peaks and the peaks shared by the other three
algorithms, we evaluated the motif enrichment of these two
sets of peaks (seeMaterials andMethods). In all five tissues,
the DFilter-only peaks were significantly more enriched in
known transcription factor motifs than the peaks shared by
the other three algorithms but not called by DFilter (Sup-
plementary Figure S20). In particular, two of the most en-
riched motifs correspond to the Pitx1 transcription factor
regulates genes involved in limbmorphogenesis (55) and the
Sox family of transcription factors has been assigned im-
portant roles in the specification and differentiation of the
neuronal lineage (56). The Pitx1 motif was more enriched
in the DFilter-only peaks than in the peaks shared by the
other three algorithms in limb and face, while the Sox3 mo-
tif was more enriched in the DFilter-only peaks than in the
shared peaks in midbrain, hindbrain and neural tube (Sup-
plementary Figure S20, Supplementary Table S9).
For comparison, we performed de novo motif discovery
on the top 2000 peaks shared by Hotspot2, MACS2, and
HOMER but not by DFilter. The three most enriched mo-
tifs were all related to the insulator binding protein CTCF
(57) in all five tissues, while these CTCF motifs were much
less enriched among DFilter-only peaks (Supplementary
Figure S20, Supplementary Table S9).
Wewanted to confirm the results of ourmotif analysis us-
ing ChIP-seq data of transcription factors in the same tis-
sues, but we only found CTCF ChIP-seq data on P0 mid-
brain and hindbrain tissues (Materials andMethods). Thus
we compared the top 2000 DNase peaks with the CTCF
ChIP-seq peaks in the corresponding tissues, and found that
91% and 95% of the DNase peaks shared by Hotspot2,
MACS2 andHOMER (among the top 2000 peaks called by
each algorithm) overlapped CTCF ChIP-seq peaks in mid-
brain and hindbrain, respectively, while much smaller over-
laps were observed for DFilter-only peaks (28% and 31%).
In conclusion, DFilter preferentially identifies broad
DNase peaks with multiple evicted nucleosomes, which are
likely bound by tissue-specific transcription factors. In com-
parison, Hotspot2, MACS2 and HOMER preferentially
identify narrow DNase peaks with a single evicted nucle-
osome, which are bound by CTCF. These CTCF-bound
DNase peaks shared by the three algorithms are likely to
function as insulators or regulate chromatin structures dur-
ing development.
The top H3K27ac peaks called by the best-performing algo-
rithms mostly overlap
Averaged over seven tissues, HOMER achieved 1–3%
higher PR-AUCs than the four next best H3K27ac al-
gorithms, MUSIC-punctate, MACS2, DFilter, and F-seq
(Figure 1, Supplementary Table S8B).We compared the top
peaks byHOMER,MUSIC-punctate,MACS2 andDFilter
but omitted F-seq for further comparison because, as men-
tioned above, F-seq called many peaks and the low-ranked
F-seq peaks were not reproducible between biological repli-
cates. Figure 2C and Supplementary Figure S16C show the
PR curves of these algorithms for limb and midbrain. In
contrast to theDNase results, the fourH3K27ac algorithms
shared many of their top 200 peaks––95 and 102 of these
peaks were called by all four algorithms for limb and mid-
brain, respectively (Figure 2D and Supplementary Figure
S16D). The H3K27ac peaks called by all four algorithms
overlapped 28 and 33 VISTA regions and achieved 53.6%
and 66.7% precision, respectively, higher than the DNase
peaks called by all four algorithms. The results for other
tissues are in Supplementary Figures S21–S22 and the re-
sults for the top 2,000 peaks in all tissues are in Supplemen-
tary Figure S23. The conclusions remain the same––the top
H3K27ac peaks called by the top algorithms were largely
shared, and these shared peaks achieved high precisions in
predicting VISTA enhancers in the respective tissues. We
tested whether using only these H3K27ac peaks called by
all four algorithms could lead to a better performance, but
it did not improve the average PR-AUC (0.32) beyond that
of HOMER (0.34).
Contrasting the DNase or the H3K27ac signal in one tis-
sue against a distant tissue substantially improved the perfor-
mance of enhancer prediction
Thus far, we have used DNase peaks or H3K27ac peaks
called from a particular tissue for predicting enhancers in
the same tissue. Given the tissue specificity of many en-
hancers, we hypothesized that peaks having significantly
higher signal in a target tissue as compared to a contrast
tissue were more likely to be active enhancers in the target
tissue. Thus, we next explored whether we could improve
the accuracy of enhancer prediction using differential sig-
nals between different tissues. For DNase, we focused on
peaks called by DFilter and Hotspot2 because they per-
formed well individually but did not share many of their
top peaks. For H3K27ac peaks, we focused on those called
by HOMER because, as described in the previous section,
four H3K27ac algorithms called highly similar peaks and
among them, HOMER had the highest average PR-AUC.
Our differential signal approach was first tested in neu-
ral tube. We called DNase peaks in neural tube and then
reranked these peaks according to the differential DNase
signal between neural tube and a contrast tissue. We tested
three metrics for computing differential DNase signals:
sequencing-depth normalized signal level (abbreviated as
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‘signal’ in figure legends); sequencing-depth normalized sig-
nal level followed by log transformation (abbreviated as
‘log’); and sequencing-depth normalized signal level fol-
lowed byZ-score transformation (abbreviated as ‘Z-score’).
We used each of the other four tissues with DNase data as
the contrast tissue and obtained different results: using face
or limb increased the PR-AUC, while using hindbrain or
midbrain decreased the PR-AUC. Thus, we concluded that
the contrast tissue needs to be ‘distant’ from the tissue under
investigation in order for the differential signal to be predic-
tive of enhancers.
To formulate a method for quantifying the distance be-
tween two tissues, we performed principal component anal-
ysis (PCA) on the DNase signal profiles of the five tissues
computed on the neural tube DNase peaks (Figure 3A).
All ChIP-seq data used in this study were generated by the
sameENCODEproduction center (led by BingRen) and all
DNase-seq data were generated in the same production cen-
ter (led by John Stamatoyannopoulos;Materials andMeth-
ods), and we did not observe batch effects upon the PCA.
The first two principal components accounted for 96% of
the variance in the data; thus, we defined the distance us-
ing the Euclidean distance defined by the first two princi-
pal components (i.e. the straight-line distance between the
dot for each tissue and the dot for neural tube in Figure
3A). We observed a high Pearson correlation (R2 = 0.78)
between the change in PR-AUC for predicting enhancers
and the distance between the two tissues (Figure 3B). Face
and limb are distant from neural tube, and using either one
of them as the contrast tissue for neural tube led to an in-
crease in PR-AUC of 0.09. On the other hand, midbrain
and hindbrain are close to neural tube; using either one of
them as the contrast tissue led to a decrease in PR-AUC of
0.04 or 0.12, respectively. Similar results were observed for
predicting enhancers in the other four tissues using DFilter
or Hotspot2 peaks (Supplementary Figures S24 and S25).
Among the three metrics for computing differential DNase
signals, the signal metric worked the best (Supplementary
Figure S26).
Figure 4 shows the PR curves of the DNase peaks called
by DFilter or Hotspot2 (solid red and blue lines, respec-
tively), using the difference in DNase signals between the
tissue under investigation and the most distant tissue. It
is apparent that using differential DNase signals substan-
tially improved PR-AUCs over using DNase signal from
the tissue under investigation alone (dotted red line). The
improvement is large for all five tissues (0.06–0.20) and
most dramatic for face, which improved from a PR-AUC
of 0.12 to 0.32 for DFilter peaks (a 167% increase). The
improvements arise mostly from increased precision in the
top-ranked peaks––the peaks that have the greatest impact
on guiding experimental testing. For example, top DFilter
peaks as ranked by DNase signal in face alone had <25%
precision when overlapped with VISTA regions (i.e. <25%
of these peaks were active in face according to VISTA), but
the top ranked DFilter peaks according to the differential
DNase signal between face andmidbrain achieved 75% pre-
cision (comparing the solid red line with the dashed red line
in Figure 4A).
The similarity of the PR curves in Figure 4 for DFilter
and Hotspot2 may seem surprising because, as noted pre-
viously, the top 2000 peaks called and ranked by these al-
gorithms were largely non-overlapping. Indeed, only 32.7–
54.2% of the top 2000 original DFilter and Hotspot2 peaks
overlap but 91.4–96.9% of the top 2000 reranked DFilter
and Hotspot2 peaks overlap (Supplementary Figure S27).
These results highlight that DFilter and Hotspot2 call a
similar overall set of peaks, but the two algorithms rank
their peaks quite differently.
We performed the same analysis using differential
H3K27ac signals between the eight tissues with H3K27ac
ChIP-seq data. We included liver as a possible contrast tis-
sue but did not compute its PR-AUCbecause, as mentioned
above, there are only eight validated VISTA enhancers in
liver. Of our threemetrics, differentialZ-scores of H3K27ac
signals most precisely predicted enhancers (Supplementary
Figure S28). Figure 3C shows the projection of the eight
tissues in the first two principal components, revealing that
hindbrain, midbrain and forebrain are the three closest tis-
sues to neural tube, while heart and liver are the two most
distant. As for DNase, we observed a strong correlation be-
tween the change in PR-AUC and the distance between the
two tissues (Figure 3D). Using heart or liver as the contrast
tissue for neural tube led to a 0.04–0.05 improvement in PR-
AUC, while using any of the three brain regions resulted
in a 0.08–0.10 decrease in PR-AUC. Similar results were
observed for using differential H3K27ac signals to predict
enhancers in the other six tissues (Supplementary Figure
S29). The tissue distances computed using H3K27ac sig-
nals at H3K27ac peaks are strongly correlated with those
computed using DNase signals at DFilter DNase peaks (R2
= 0.80–0.96; Supplementary Figure S30) or DNase signals
at Hotspot2 DNase peaks (R2 = 0.79–0.98; Supplementary
Figure S31), indicating that our approach to computing dif-
ferential signals is generally applicable.
Figure 4 also includes the PR curves for the HOMER
H3K27ac peaks ranked according to the differential
H3K27ac Z-scores between a tissue under investigation and
its most distant tissue (solid green lines). These PR curves
exhibit improvement over the H3K27ac peaks ranked by
HOMER in the tissue under investigation alone (dotted
green lines), with increases in PR-AUC from 0.02 to 0.07
seen across seven tissues. The improvement was largest for
forebrain and across the entire range of recall.
Contrasting DNase signals or H3K27ac signals in one tissue
against a group of tissues weighted by their distances led to
further improvements
For the results shown in the previous section, contrasting
against themost distant tissue typically produced the largest
increase in performance, although there were a few excep-
tions. For example, for Hotspot2 peaks called in limb, mid-
brain was the most distant tissue from limb, but the second
most distant tissue––neural tube––led to the greatest im-
provement (a 0.02 PR-AUC difference; Supplementary Fig-
ure S25C). Thus, we explored the approach of contrasting
the target tissue against a large group of tissues, weighting
each contrast tissue by its distance to the tissue under in-
vestigation. We tested this approach using the existing five
tissues for DNase and eight tissues for H3K27ac. We ob-
served slight improvements for H3K27ac, but slightly worse
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky753/5077601 by U
niversity of M
assachusetts M
edical School user on 17 Septem
ber 2018
10 Nucleic Acids Research, 2018
Figure 3. Enhancer prediction accuracy is positively correlatedwith the distance between the contrast tissue and the tissue under investigation. (A) Principal
component analysis (PCA) for DNase signal profiles in DNase peaks called by Hotspot2 in neural tube. The distance between two tissues in the scatter
plot is computed using the first two principal components (PCs) of the signal profiles in these two tissues. Neural tube––the tissue under investigation––is
in red. (B) Correlation between the distance of the contrast tissue and the improvement of enhancer PR-AUC for the Hotspot2 DNase peaks in neural
tube. (C) PCA for the signal profiles of the HOMER H3K27ac peaks in neural tube. (D) Correlation between the distance of the contrast tissue and the
improvement of enhancer PR-AUC for the HOMER H3K27ac peaks in neural tube.
results for DNase, suggesting this approach may require a
sufficiently large number of tissues to be effective.
To expand our tissue coverage, we took all 24 DNase
datasets on mouse tissues from ENCODE that were
mapped to the mm10-minimal mouse genome build at the
time of our study. For H3K27ac, we included eight tissues
at e11.5 and e12.5. We also added the intestine from P0,
which we had previously found to be the most distant from
all other tissues by hierarchical clustering of gene expression
profiles. These datasets are listed in Supplementary Tables
S1B-C.
We performed PCA and calculated Euclidean distances
as described in the previous section. We then computed dif-
ferential DNase signals between the tissue under investi-
gation and the weighted sum of the DNase signals in the
other 23 tissues, with the weights proportional to the dis-
tances and summing to one. For H3K27ac, we calculated
the difference in the Z-scores between the tissue under in-
vestigation and the weighted sum of the H3K27ac Z-scores
in the other 16 tissues. We continued to observe a positive
correlation between the improvement in PR-AUC and the
distances from the individual contrast tissues (Supplemen-
tary Figures S32–S34). Figure 5 compares the results us-
ing the larger group of weighted tissues (solid lines) with
the results using the most distant tissue among the smaller
group of tissues (dotted lines, which correspond to the solid
lines in Figure 4). Using weighted tissues over the single
most distant tissue led to 0.02–0.03 increases in PR-AUC
for DNase peaks (for both DFilter peaks and Hotspot2
peaks) in four out of five tissues, with face being the excep-
tion, showing a decrease of 0.01 for Hotspot2 peaks. For
the H3K27ac peaks called by HOMER, a slight increase in
PR-AUCwas observed in five tissues (0.01–0.03) while neu-
ral tube and heart showed no change. In summary, for the
larger groups of tissues (24 forDNase and 17 forH3K27ac),
using weighted tissues was consistently, albeit slightly, bet-
ter than using the most distant tissue alone (Supplementary
Figure S35). Despite its large distance from all other tissues,
the addition of the P0 intestine did not significantly change
our results (data not shown).
To further investigate the difference in performance be-
tween signal and differential signal, we compared the ranks
for the top 2000 peaks as determined by these two metrics
(Supplementary Figures S36-S38). Differential signal as-
signs poor ranks tomany of the top 2000 peaks as ranked by
the original algorithms, more so for DNase peaks than for
H3K27ac peaks (compare Supplementary Figures S36–S37
with S38). Accordingly, the differential signal approach led
to a greater improvement in enhancer prediction for DNase
peaks (especially Hotspot2 peaks) than forH3K27ac peaks.
This difference may also be attributable to the greater abun-
dance of called DNase peaks versus H3K27ac peaks (17
fold more on average), which results in many of the called
DNase peaks being non-enhancer regulatory elements or
false positives. Indeed, when we examined the top 2000
DNase peaks by DFilter or Hotspot2, 11.5–51.3% and
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Figure 4. Improvement in VISTA enhancer prediction achieved by differential DNase or H3K27ac signals between two distant tissues. The PR curves of
the DFilter or Hotspot2 DNase peaks and the HOMER H3K27ac peaks, ranked by differential signals (solid lines) or original algorithms (dotted lines),
were evaluated using VISTA enhancers in (A) face, (B) hindbrain, (C) limb, (D) midbrain, (E) neural tube, (F) forebrain and (G) heart. PR-AUC values
are indicated in the legend of each panel.
23.4–70.3%of themwere ranked poorly (beyond 20k) by the
differential signal metric, suggesting many of these might
be false positives. In contrast, only 13.8–27.6% of the top
2000 H3K27ac peaks were ranked beyond 5k, indicating a
smaller fraction of false positives.
We also performed motif enrichment analysis (see Meth-
ods) to compare the top 2000 peaks called and ranked
by each algorithm (DFilter or Hotspot2 for DNase and
HOMER for H3K27ac) with the top 2000 peaks called by
the corresponding algorithm but reranked by differential
signals. The reranked Hotspot2 DNase peaks were signif-
icantly more enriched in known transcription factor mo-
tifs than the peaks originally ranked by Hotspot2 in all
five tissues (Supplementary Figure S40), and for four out
of five tissues when considering DFilter peaks (except neu-
ral tube; Supplementary Figure S39). Reranked HOMER
H3K27ac peaks were significantly more enriched in mo-
tifs than the peaks originally ranked by HOMER in all
seven tissues (Supplementary Figure S41). In particular, we
observed a higher enrichment for the Pitx1 motif in the
reranked DNase and H3K27ac peaks than in the original
peaks in limb and face and a higher enrichment for the Sox3
motif in the reranked DNase and H3K27ac peaks than in
the corresponding original peaks in most of the brain tis-
sues (Supplementary Figure S39–S41), consistent with the
known function of Pitx1 in limb development and Sox3 in
neural development (55,56).
DNase and H3K27ac peaks with the highest differential sig-
nals are near differentially expressed genes
We asked whether the top TSS-distal DNase or H3K27ac
peaks (≥2 kb away from any GENCODE-annotated TSS)
were near genes specifically expressed in the same tissue, hy-
pothesizing that the peaks near tissue-specific genes were
more likely bona fide tissue-specific enhancers.We analyzed
the top 2000 DNase peaks (called by DFilter or Hotspot2)
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Figure 5. Additional improvement in enhancer prediction achieved by contrasting against a group of distance-weighted tissues. We used 24 tissues for
DNase and 17 tissues for H3K27ac, weighted proportionally to their distances from the tissue under investigation. The PR curves using weighted tissues
are drawn with solid lines, and the PR curves using the most distant tissue alone are drawn in dotted lines of the corresponding colors for comparison.
VISTA enhancers in the tissue of interest were used for evaluating the precision and recall in (A) face, (B) hindbrain, (C) limb, (D) midbrain, (E) neural
tube, (F) forebrain and (G) heart. PR-AUC values are indicated in the legend in each panel.
and the top 2000 H3K27ac peaks (called by HOMER),
ranked by the default approach of the peak callers or by dif-
ferential signals against weighted tissues as described in the
previous section. To quantify tissue-specific genes, we used
RNA-seq data to compute differential expression (quanti-
fied as log fold change), retaining only the genes with pos-
itive log fold changes in the corresponding tissue against
contrast tissues (see Materials and Methods). If the tissue
under investigation was brain-related (forebrain, midbrain,
hindbrain or neural tube), we computed differential expres-
sion against the other four non-brain tissues (face, limb,
heart, and liver). Conversely, if the tissue under investiga-
tion was not brain-related, we instead computed differential
expression against the four brain tissues. We identified 1747
upregulated genes in face, 2068 in limb, 988 in midbrain,
1071 in hindbrain, 988 in neural tube with the adjusted P-
value ≤ 0.05. Supplementary Figure S42A illustrates that
the neighboring genes of the top 2000 DFilter peaks iden-
tified using differential DNase signals were more differen-
tially expressed in the corresponding tissue than the neigh-
boring genes of the top 2000 DFilter peaks identified by
the default metric provided by the DFilter algorithm, and
the differences were significant in two out of five tissues (P-
value < 0.05). The differences were significant in three tis-
sues for Hotspot2 DNase peaks and significant in all seven
tissues for HOMER H3K27ac peaks (Supplementary Fig-
ure S42B and C).
Differential H3K27ac signals led to substantial improvement
in e12.5 heart enhancer prediction
As part of the ENCODE consortium, the Pennacchio lab
used transgenic mouse assays to test 150 regions of the
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mouse genome for enhancer activity, identified from 50
H3K27ac peaks each from the e12.5 forebrain, heart, and
limb tissues. Due to the nature of transgenic mouse assays,
the enhancer activities of these regions were tested in all
mouse tissues, not just the tissues in which the peaks were
identified. Predictions were solicited to rank these regions
before the release of the experimental data, i.e. this was a
blind test of the computational methods.We ranked the 150
regions for each tissue using differential H3K27ac signals
and submitted the predictions to the ENCODE Portal on
21 March 2017, 1.5 months before the Pennacchio lab re-
leased the experimental results at the VISTA database (Sup-
plementary Table S4). The transgenic mouse data on these
150 regions are described in a preprint (BioRxiv: https:
//doi.org/10.1101/166652).
We compared the performance of three ranking meth-
ods (SeeMethods): H3K27ac peak ranks downloaded from
the ENCODE Portal, which were called and ranked using
MACS2, H3K27ac peaks called and ranked by HOMER,
and H3K27ac peaks called using HOMER but ranked by
contrasting H3K27ac signals in the e12.5 forebrain, heart,
or limb against the other 16 tissues as described above. We
did not test the approach using differential DNase signals
because no DNase-seq data were available for these three
tissues at e12.5. The PR-AUC values for the three methods
are comparable for forebrain and limb, but the differential
H3K27acmethod is substantially better for heart (PR-AUC
= 0.75, while ENCODE and HOMER tied at 0.48), with
the improvement spanning the entire range of recall (Fig-
ure 6B).
We were surprised that the differential H3K27ac method
did not outperform the other two methods for the e12.5
limb enhancers, in contrast with the results for e11.5 en-
hancers (Figures 4 and 5). One reason for this is that few
of the e12.5 limb enhancers are limb-specific, whereas many
of the e11.5 limb enhancers are. Among the 150 regions, 32
are active in the e12.5 limb, but only two of these regions
(6.25%) are exclusively active in limb at this stage. In sharp
contrast, 146 of the 280 (52.14%) e11.5 limb enhancers are
exclusively active in limb (Chi-square P-value = 2.15E–6).
The difference between e12.5 and e11.5 is smaller for fore-
brain and heart. Seven of the 30 (23.3%) e12.5 forebrain en-
hancers are exclusively active in forebrain, compared with
146 of the 437 (33.4%) e11.5 forebrain enhancers (P-value
= 0.35). Twelve of the 22 (54.5%) e12.5 heart enhancers are
exclusively active in heart, compared with 187 of the 235
(79.7%) e11.5 heart enhancers (P-value = 0.016).
To investigate whether the differential H3K27ac ap-
proach is particularly effective in identifying tissue-specific
enhancers, we examined the 280 e11.5 limb enhancers in
greater detail. We separated these 280 enhancers into two
groups: 146 (52.14%) e11.5 limb enhancers that are exclu-
sively active in limb, and the remaining 134 enhancers ac-
tive in limb and another e11.5 tissue. We computed PR-
AUC separately for these two groups of enhancers against
the 2276 VISTA regions that are inactive in the limb. Note
that the baseline performance as measured by PR-AUC is
the percentage of positives in the test set, which would be
146/2,276 or 0.064 for limb-specific enhancers and 0.059
for the enhancers that are active in limb and another tis-
sue. Compared with this baseline performance, HOMER
H2K27ac achieved PR-AUC of 0.22 and 0.24 respectively,
while the weighted H3K27ac Z-score achieved PR-AUC of
0.30 and 0.27. Indeed, the differential H3K27ac approach
is more effective in predicting limb-specific enhancers than
enhancers active in limb and other tissues (PR-AUC im-
proved by 0.08 and 0.03 respectively); yet, the differential
H3K27ac approach shows an improvement for both groups
of enhancers.We observed similar results for the differential
DNase approach and in other tissues.
Further validation with MPRA CRE-seq enhancers
So far, our performance evaluations have been based
on VISTA regions. We further tested the differen-
tial signal approach using a completely different gold
standard––enhancers identified by massively parallel
reporter (MPRA) CRE-seq assays performed on mouse P0
retina and adult cerebral cortex (54). We used the DNase
peaks of P7 retina and the DNase peaks and H3K27ac
peaks of P0 forebrain, the best matching biosamples
with ENCODE data. For retina DNase peaks, ranking
by differential signal showed a significant improvement
over ranking by the original algorithm, with PR-AUC
increasing from 0.28 to 0.42 (Figure 6D). Forebrain
DNase peaks and H3K27ac peaks also showed modest
improvements, with PR-AUCs increasing from 0.08 to 0.12
and 0.12 to 0.13 respectively (Figure 6E and F). Overall,
these PR-AUC values are lower than those for VISTA
enhancers, partially because of the lack of a perfect match
in developmental time points between the biosamples with
epigenetic and MPRA data. Nevertheless, these results
validate the differential signal approach.
DISCUSSION
Chromatin accessibility (DNase-seq or ATAC-seq) and hi-
stone mark ChIP-seq data have been widely used to pre-
dict enhancers in specific cell types. Although sophisti-
cated algorithms have been developed to integrate multi-
ple types of data in multiple cell and tissue types to pre-
dict enhancers, calling peaks using a single dataset remains
a widely used approach for predicting enhancers in the cor-
responding cell type (22,23,33). In this study, we systemati-
cally compared nine algorithms for calling peaks on DNase
or ChIP-seq signals with the goal of predicting enhancers.
We found that for the same data, different algorithms pre-
dicted widely varying numbers of peaks, with systematically
different widths and boundaries. We implemented the EN-
CODE uniform processing pipeline for all nine algorithms
we tested in order to filter peaks not reproducible between
the two biological replicates, and observed a 30–50% reduc-
tion in the peaks called by most algorithms. The uniform
processing pipeline also substantially decreased the varia-
tions among the final numbers of peaks across the algo-
rithms.
The algorithms we tested were representative of pub-
lished algorithms applicable to DNase-seq and histone
mark ChIP-seq data. Earlier efforts have been made to
benchmark peak calling performance, but because of the
large number of peak callers available such efforts are
far from complete. Thomas et al. (58) selected six out
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Figure 6. Validation of our differential signal approaches with a blind test and MPRA enhancers. (A–C) A blind test of the differential H3K27ac signal
method for predicting e12.5 transgenic mouse enhancers in (A) forebrain, (B) heart and (C) limb. We used 17 contrast tissues as in Figure 5, weighted
proportionally to their distances from the tissue under investigation. VISTA enhancers in the tissue of interest were used for evaluating the precision and
recall. The predictions were submitted to the ENCODE Portal before the release of experimental results, and hence were a blind test. PR-AUC values are
indicated in the legend in each panel. (D, E) Using the differential DNase signal for predicting MPRA CRE-seq enhancers in retina (D) and (E) cerebral
cortex. (F) Using the differential H3K27ac signal for predicting MPRA CRE-seq enhancers in cerebral cortex. We used the same set of contrast tissues as
in Figure 5, weighted proportionally to their distances from the tissue under investigation.
of 30 available peak callers for ChIP-seq data and com-
pared their performance on ChIP-seq data for H3K4me3
and H3K36me3, as well as various transcription factors.
They found BCP and MUSIC performed best on these two
types of histone ChIP-seq data, assessed by actively tran-
scribed genes. Koohy et al. (32) compared F-seq, Hotspot,
MACS2 and ZINBA on DNase-seq data, using transcrip-
tion factor ChIP-seq peaks in the same cell type as the gold
standard. They found F-seq to be slightly more sensitive
than Hotspot and MACS2 and ZINBA to be the least sen-
sitive. Our work complements these earlier benchmarking
efforts.
Using VISTA enhancers as the gold standard, we eval-
uated the predictiveness of TSS-distal peaks (≥2 kb away
from any GENCODE-annotated TSS) for DNase and five
histone marks (H3K4me1/2/3 and H3K9/27ac) called by
the various algorithms. H3K4me1, H3K4me2 and H3K9ac
have all been shown to be enriched at known enhancers and
were used to predict enhancers (6,59,60). We found TSS-
distal DNase-seq and H3K27ac peaks to be substantially
more accurate in identifying VISTA enhancers than TSS-
distal H3K4me1/2/3 and H3K9ac peaks. Our results agree
with an earlier study (12), which compared these ‘single epi-
genetic features’ using a smaller set of VISTA regions (they
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used 546 regions, while we used 2,556 regions). Another
study showed that H2BK20ac was more predictive of en-
hancers than H3K27ac (61). We reanalyzed the ChIP-seq
data in that work and confirmed their results; however, the
ENCODE H3K27ac ChIP-seq data achieved higher PR-
AUC than both the H2BK20ac and H3K27ac ChIP-seq
data used by Kumar et al. (0.42 versus 0.37 and 0.32; all
peaks called by HOMER).
For DNase data, we found DFilter to be the most accu-
rate in predicting enhancers as well as the most consistent
in ranking called peaks between pairs of biological repli-
cates, followed by Hotspot2. The top DNase peaks called
by DFilter were mostly not shared by the top peaks of the
other algorithms; this corresponded with the distinctively
higher performance of DFilter. DFilter uses a linear detec-
tion filter known as the Hotelling observer to perform win-
dowed smoothing of the DNase signal to achieve optimal
signal detection accuracy (42). This approach is likely to de-
tect DNase peaks with distinct shape characteristics. Mean-
while, the other algorithms do not employ techniques for
taking into account the shapes of peaks and appear more
focused on the raw signal level. As a result, most of the top
DFilter-unique DNase peaks were broad and multimodal,
suggesting multiple consecutive evicted nucleosomes. On
the other hand,most of the peaks called by other algorithms
(but notDFilter) were of high signal and unimodal, suggest-
ing a single evicted nucleosome. The two sets of peaks also
differ in their enriched TF motifs, with DFilter-only peaks
enriched in tissue-specific motifs while the peaks shared by
the other algorithms enriched in the CTCF motif. Further-
more, a vast majority of the shared peaks overlap CTCF
ChIP-seq peaks based on further analysis in midbrain and
hindbrain. These results are consistent with our earlier find-
ing that CTCF binding sites are flanked by multiple well-
positioned nucleosomes (62), i.e. a single evicted nucleo-
some at the center. Thus,Hotspot2,MACS2, andHOMER,
but not DFilter, preferentially identify DNase peaks with a
single evicted nucleosome and bound by CTCF.
For H3K27ac ChIP-seq, HOMER was the most pre-
dictive algorithm, followed closely by MUSIC punctate,
MACS2, DFilter and F-seq. In contrast to DNase peaks,
many of the top H3K27ac peaks called by HOMER were
shared by other top performing algorithms (MUSIC punc-
tate, MACS2, and DFilter). Because the same algorithm
was used by DFilter to identify DNase and H3K27ac peaks
(42), this suggests that, in contrast to DNase peaks, ex-
isting algorithms did not identify multiple distinct classes
of H3K27ac peaks that could be predictive of active en-
hancers. Note that DNase-seq identifies many types of reg-
ulatory regions, of which enhancers are a subset. As il-
lustrated above, the DNase peaks that are preferentially
identified by Hotspot2, MACS2 and HOMER are likely
CTCF-bound insulators; such regions tend not to over-
lap enhancers with high H3K27ac signals. Furthermore,
H3K27ac peaks are much wider thanDNase peaks, and the
H3K27ac peaks that contain a multi-evicted-nucleosome
DNase peak in their troughs may not differ substantially
from the H3K27ac peaks that contain a single-nucleosome
DNase peak in their troughs.
We substantially improved the prediction of VISTA en-
hancers by reranking DNase and H3K27ac peaks with dif-
ferential signals against a distant tissue. Moreover, the top
peaks after reranking are significantly more enriched in
known TF motifs than the top peaks originally ranked by
the peak callers, and the genes closest to the top peaks af-
ter reranking were significantly more upregulated in the tis-
sue of interest than the genes closest to the top peaks with-
out reranking. These three lines of independent evidence
support the validity of the differential signal approach.
Furthermore, even though DFilter performed better than
Hotspot2 in ranking peaks, reranking led to nearly iden-
tical performance for the peaks called by these two algo-
rithms. This suggests that as long as a peak caller identifies
true positives peaks in its collection, reranking using differ-
ential signals can push these true positive peaks to the top
of the list.
The differential signal approach led to a more substan-
tial improvement for DNase data than for H3K27ac data,
which could be due to several reasons. First, many more
peaks are called for the DNase datasets than for H3K27ac
datasets in the same tissue (17-fold more averaged over
the nine algorithms). This is because DNase hypersensi-
tivity characterizes all classes of regulatory elements, in-
cluding enhancers, promoters, silencers, insulators, bound-
ary elements, and nuclear matrix attachment regions, while
H3K27ac is predominantly enriched at active enhancers
and promoters. A case in point is potential insulators bound
by CTCF––over 90% of the top 2000 DNase peaks that
are shared among Hotspot2, MACS and HOMER over-
lap CTCF ChIP-seq peaks, as mentioned above. Second,
active enhancers are more tissue-specific than other types
of regulatory elements, e.g., promoters, poised enhancers,
unannotated promoters, insulators, and matrix attachment
regions. Differential DNase signal would rank the other
types of elements low, thus improving the power to pre-
dict active enhancers. One example is CTCF-bound DNase
peaks, which are preferentially identified by Hotspot2,
MACS2 and HOMER, as shown above. Such potential in-
sulators tend to be ubiquitously active across multiple cell
types (63), and would be ranked low by our differential sig-
nal approach. Indeed, 35%, 46% and 65% of the top 2000
DNase peaks identified byDFilter, Hotspot2 andHOMER
overlapped CTCF ChIP-seq peaks in the corresponding
tissue (percentages averaged between midbrain and hind-
brain), while after reranking using our differential signal ap-
proach, only 11% of the top 2000 DNase peaks for all three
algorithms overlapped CTCF peaks. In contrast, H3K27ac
would not benefit as much from differential scoring since
it is already specific to active enhancers. Third, the DNase-
seq datasets we analyzed had higher sequencing depths than
the H3K27ac datasets (196–334 M versus 11–22 M), and
a higher sequencing depth corresponds to a higher power
in detecting peaks. The third possibility does not seem to
play a large role because when we downsampled the DNase
datasets to 5 M reads we did not observe a decrease in the
DNase peak number called by DFilter.
Several earlier studies reported that differential sig-
nals led to improved performance in enhancer prediction.
Zeitlinger and colleagues performed differential H3K27ac
analysis for identifying Drosophila dorsoventral enhancers
(64). Several studies showed that many differentially DNA
methylated regions overlap with enhancers (12). Monti et
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al. noted a DNase I enrichment score that contributed sig-
nificantly to their model performance on predicting limb
VISTA enhancers––the enrichment of DNase signal in the
limb over a headless embryo (18). We tested the headless
embryo as a contrast tissue for computing the differential
DNase signal in limb, and indeed we observed improved
PR-AUC of 0.43 and 0.44 for DFilter and Hotspot2 DNase
peaks over the original ranking by DFilter or Hotspot2
(PR-AUC = 0.40 and 0.35). However, the headless embryo
is much closer to the limb than the three brain tissues (mid-
brain, hindbrain, and neural tube). Indeed, using any of
these three brain tissues as the contrast tissue for computing
differential DNase signal achieved greater improvements
(PR-AUC= 0.47, 0.49 and 0.48 for DFilter peaks and 0.48,
0.49 and 0.50 for Hotspot2 peaks respectively). Thus, our
study corroborates the findings by previous studies, and we
additionally show that the performance can be further im-
proved by choosing a different contrast tissue.
We have extended previous work by thoroughly exploring
the differential DNase and H3K27ac approach for predict-
ing developmental enhancers in seven mouse tissues. One
novelty of our study is that our results indicate that it is
important to choose the most distant tissue as the contrast
tissue (Supplementary Figures S32-S34). If the tissue un-
der investigation is a brain tissue, it works well to contrast
with a non-brain tissue, and vice versa (Supplementary Fig-
ures S32-S34); nevertheless, the exact choice of the contrast
tissue still impacts the performance. Furthermore, the ap-
proach may be sensitive to the differential qualities of the
two datasets being contrasted, although this was not an is-
sue with the high-quality ENCODE data produced by the
same labs. Indeed, PCA did not reveal batch effects in the
DNase-seq and ChIP-seq data we used; however, batch cor-
rection may be necessary when datasets are from different
sources or protocols. To simplify the process of choosing
the contrast tissue, we extended our approach by contrast-
ing against a broad group of tissues, weighted by their dis-
tances from the tissue under investigation. This extension
improved the results moderately, but eliminated the reliance
on a particular contrast tissue. We should be able to use the
large panel of ENCODE data as contrast tissues for differ-
ential DNase andH3K27ac analysis in any future cell types.
The good performance of our method in a blind test of
e12.5 heart enhancers and in predicting MPRA enhancers
in postnatal retina and cerebral cortex further supports the
predictive power of our approach.
Monti et al. used machine learning approaches to predict
limb VISTA enhancers (18). Using 50 chromatin features
measured on the limb tissue and sequence features, they
achieved amedian PR-AUCof 0.545 upon 10-fold cross val-
idation, higher than the highest PR-AUCwe achieved using
a single feature (PR-AUC = 0.50 for weighted differential
DNase signal). Nevertheless, our single-feature approach
achieves competitive performance with machine learning
approaches that require many more input data types, which
are not always available for the biological system under
study. Note that Monti et al. also focused on TSS-distal
regions and used two features called ‘DNase enrichment’,
which allows a direct comparison of their performance with
ours. Furthermore, our approach does not require training
and thus is more likely to maintain its performance across
different tissues, while machine learning models trained us-
ing the data in one tissue often do not perform as well in
another tissue.
Although the differential signal approach achieves im-
proved overall performance, it may distort the overall en-
hancer landscape and eliminate or demote the enhancers
that are active inmany cell types. Our comparison ofVISTA
enhancers that are limb-specific vs. those that are active in
limb and other tissues indicates that the differential signal
approach works well for both types of enhancers; neverthe-
less, the approachmay not work well for ubiquitously active
enhancers.
Clear demarcation of peaks is important for defining in-
dividual enhancers and quantifying their activities in spe-
cific cell types. The different algorithms predict peaks with
widely different widths and accordingly different bound-
aries. Some algorithms do not call peaks with base-pair res-
olution (e.g., DFilter peaks have a resolution of 200 bp,
which is too low for DNase peaks). Based on visualizing
signal tracks using theUCSC genome browser (Supplemen-
tary Figures S12–S14), Hotspot2 DNase peaks frequently
have more appropriate boundaries than the peaks of the
other algorithms. Nevertheless, more systematic analyses
are required. Our three gold standards––VISTA enhancers,
motif enrichment, and tissue-specific genes––do not have
sufficient spatial resolution for evaluating which peak sets
have the most accurate widths and boundaries; therefore,
we avoided performing such analyses in this study by resiz-
ing all peaks to the same width. Other types of functional
data such asmassively parallel reporter assaysmay have suf-
ficient resolution.
We used VISTA enhancers as a gold standard for en-
hancer prediction; this has been done in previous stud-
ies (12,14). Although VISTA enhancers are the most ex-
tensively validated mammalian enhancers, they have sev-
eral disadvantages as the gold standard. First, there are
only ∼2,500 VISTA regions and their activities have only
been measured during embryonic development. Although
we evaluated DNase and H3K27ac data in the same tis-
sue and developmental time point as VISTA enhancers, it is
still likely that our results are limited due to the small num-
ber of VISTA enhancers and our conclusions are specific
to mouse embryonic development. Second, VISTA regions
have not been randomly chosen. The VISTA regions that
were tested in early years were chosen because of high evo-
lutionary conservation. More recently, regions were chosen
from H3K27ac or EP300 ChIP-seq peaks called by MACS
(36) and CCAT (65); both algorithms approximate win-
dowed ChIP-seq reads with a Poisson model. Thus regions
that are not called by these algorithms are underrepresented
in theVISTA enhancer collection, and the PR-AUCswe ob-
tained may not reflect the performance that would be ob-
tained by testing randomly-chosen regions. Third, VISTA
enhancers may represent the strongest developmental en-
hancers while weaker enhancers can still be important for
development (66). Because our approach does not require
any training and does not have any adjustable parame-
ters, it should be less affected by the non-random selection
of VISTA regions than supervised machine learning ap-
proaches with many adjustable parameters would be. Nev-
ertheless, we further tested our differential signal approach
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using a different gold standard––postnatal retina and cere-
bral cortex enhancers identified by massively parallel re-
porter assays. Despite the mismatch in developmental time
points between the input epigenetic data and the MPRA
data, we observed improved performance by our differen-
tial signal approach over the original algorithms.
CONCLUSION
We performed extensive analysis in search of the best ap-
proach for using a single DNase-seq or histone mark ChIP-
seq dataset to predict tissue-specific enhancers. We devel-
oped a method to contrast DNase or H3K27ac signal in
one tissue against a panel of other tissues, resulting in a sub-
stantial improvement over existing algorithms, and the im-
provement is replicated in a blind test. Our approach does
not require training and can be directly applied to predict
enhancers in new cell types. Our method pertains to the sit-
uation when just one histone mark ChIP-seq or DNase-seq
experiment is available in the cell or tissue type of interest.
When multiple types of experiments are available, methods
that integrate these data may achieve better performance.
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